Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Goetz

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 16, 2009
If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology traineesTow S Tan, Tamana Walia, Eva Galanis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Oncophenotypic review and clinical correlates of phosphatase and tensin homolog on chromosome 10 hamartoma tumor syndromeMrinal M Patnaik, Sania S Raza, Sherezade Khambatta, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 2, 2023
Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancerSarah A Buhrow, Emily J Koubek, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast CancerGrace M Choong, Tanya L Hoskin, Judy C Boughey, et al.
Annals of Surgical Oncology|January 6, 2017
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?Judy C Boughey, Bruce G Haffty, Elizabeth B Habermann, et al.
Annals of Surgical Oncology|September 12, 2024
In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free SurvivalKathryn M Eckert, Tanya L Hoskin, Carrie A Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P Goetz, Vera J Suman, Yusuke Nakamura, et al.
Cancer Research|February 27, 2009
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cellsXianglin Wu, John R Hawse, Malayannan Subramaniam, et al.
Breast Cancer Research and Treatment|October 25, 2023
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancerDan Moldoveanu, Tanya L Hoskin, Courtney N Day, et al.
Annals of Surgical Oncology|July 17, 2023
Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast CancerDan Moldoveanu, Tanya L Hoskin, Courtney N Day, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 16, 2009
If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology traineesTow S Tan, Tamana Walia, Eva Galanis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
Oncophenotypic review and clinical correlates of phosphatase and tensin homolog on chromosome 10 hamartoma tumor syndromeMrinal M Patnaik, Sania S Raza, Sherezade Khambatta, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 2, 2023
Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancerSarah A Buhrow, Emily J Koubek, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast CancerGrace M Choong, Tanya L Hoskin, Judy C Boughey, et al.
Annals of Surgical Oncology|January 6, 2017
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?Judy C Boughey, Bruce G Haffty, Elizabeth B Habermann, et al.
Annals of Surgical Oncology|September 12, 2024
In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free SurvivalKathryn M Eckert, Tanya L Hoskin, Carrie A Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2019
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P Goetz, Vera J Suman, Yusuke Nakamura, et al.
Cancer Research|February 27, 2009
The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cellsXianglin Wu, John R Hawse, Malayannan Subramaniam, et al.
Breast Cancer Research and Treatment|October 25, 2023
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancerDan Moldoveanu, Tanya L Hoskin, Courtney N Day, et al.
Annals of Surgical Oncology|July 17, 2023
Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast CancerDan Moldoveanu, Tanya L Hoskin, Courtney N Day, et al.
Pageof 27